New analysis reveals outcomes are worse for Black sufferers with acute myeloid leukemia (AML) than white sufferers who obtained related intensive remedy on scientific trials.
New analysis reveals outcomes are worse for Black sufferers with acute myeloid leukemia (AML) than white sufferers who obtained related intensive remedy on scientific trials.
© 2022 CIPILLSS
Discussion about this post